Treatment with Distinct Antibiotic Classes Causes Different Pulmonary Outcomes on Allergic Airway Inflammation Associated with Modulation of Symbiotic Microbiota

MLA

Gregório Grama Cavalcante, et al. “Treatment with Distinct Antibiotic Classes Causes Different Pulmonary Outcomes on Allergic Airway Inflammation Associated with Modulation of Symbiotic Microbiota.” Journal of Immunology Research, vol. 2022, Jan. 2022. EBSCOhost, https://doi.org/10.1155/2022/1466011.

APA

Gregório Grama Cavalcante, Anna Gabriella Guimarães, Camila Pereira Queiroz-Glauss, Marcela Helena Gonçalves Pereira, Angélica Samer Lallo Dias, Laila Sampaio Horta, Jamil Silvano de Oliveira, Silvia Dantas Cangussú, Paula Prazeres Magalhães, Remo Castro Russo, & H. C. Santiago. (2022). Treatment with Distinct Antibiotic Classes Causes Different Pulmonary Outcomes on Allergic Airway Inflammation Associated with Modulation of Symbiotic Microbiota. Journal of Immunology Research, 2022. https://doi.org/10.1155/2022/1466011

Chicago

Gregório Grama Cavalcante, Anna Gabriella Guimarães, Camila Pereira Queiroz-Glauss, Marcela Helena Gonçalves Pereira, Angélica Samer Lallo Dias, Laila Sampaio Horta, Jamil Silvano de Oliveira, et al. 2022. “Treatment with Distinct Antibiotic Classes Causes Different Pulmonary Outcomes on Allergic Airway Inflammation Associated with Modulation of Symbiotic Microbiota.” Journal of Immunology Research 2022 (January). doi:10.1155/2022/1466011.